Scientists at Oxford University say that they have developed a technology that could significantly speed up testing for COVID-19.

Oxford and Prenetics aren’t the only ones looking ahead to a future in which the rapid testing market continues to boom, even as it is no longer dominated by COVID.

The University of Oxford has partnered with U.S.-based Thermo Fisher Scientific to ramp up its capacity to deliver COVID-19 testing data and help collect and quantify immune responses in its ...

The trial announced Saturday seeks to recruit 300 volunteers between the ages of 6 and 17, with up to 240 receiving the COVID-19 vaccine and the remainder a control meningitis vaccine.

The Oxford University COVID-19 vaccine is to begin testing its efficacy in children aged six to 17. It will be the first trial in children so young. Children are much less affected by the novel ...

EpiSwitch CiRT® is a first-of-its-kind precision medicine test that predicts a patient's likely response to widely used Immune Checkpoint Inhibitor (ICI) therapies. The test has shown high ...